Loading…

Expanding the Repertoire of Low‐Molecular‐Weight Pentafluorosulfanyl‐Substituted Scaffolds

The pentafluorosulfanyl (‐SF5) functional group is of increasing interest as a bioisostere in medicinal chemistry. A library of SF5‐containing compounds, including amide, isoxazole, and oxindole derivatives, was synthesised using a range of solution‐based and solventless methods, including microwave...

Full description

Saved in:
Bibliographic Details
Published in:ChemMedChem 2022-04, Vol.17 (7), p.e202100641-n/a
Main Authors: Jose, Arathy, Guest, Daniel, LeGay, Remi, Tizzard, Graham J., Coles, Simon J., Derveni, Mariliza, Wright, Edward, Marrison, Lester, Lee, Alpha A., Morris, Aaron, Robinson, Matt, Delft, Frank, Fearon, Daren, Koekemoer, Lizbé, Matviuk, Tetiana, Aimon, Anthony, Schofield, Christopher J., Malla, Tika R., London, Nir, Greenland, Barnaby W., Bagley, Mark C., Spencer, John, The Covid Moonshot Consortium
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The pentafluorosulfanyl (‐SF5) functional group is of increasing interest as a bioisostere in medicinal chemistry. A library of SF5‐containing compounds, including amide, isoxazole, and oxindole derivatives, was synthesised using a range of solution‐based and solventless methods, including microwave and ball‐mill techniques. The library was tested against targets including human dihydroorotate dehydrogenase (HDHODH). A subsequent focused approach led to synthesis of analogues of the clinically used disease modifying anti‐rheumatic drugs (DMARDs), Teriflunomide and Leflunomide, considered for potential COVID‐19 use, where SF5 bioisostere deployment led to improved inhibition of HDHODH compared with the parent drugs. The results demonstrate the utility of the SF5 group in medicinal chemistry. A range of molecules containing a pentafluorosulfanyl group have been made and tested versus known drug‐like entities. The SF5 functional group is of increasing interest as a bioisostere in medicinal chemistry. This library was tested against targets including human dihydroorotate dehydrogenase (HDHODH). A subsequent focused approach led to analogues of Teriflunomide and Leflunomide, considered for potential COVID‐19 treatment, where SF5 bioisostere deployment led to improved inhibition of HDHODH over the parent drugs.
ISSN:1860-7179
1860-7187
1860-7187
DOI:10.1002/cmdc.202100641